Gene · 8352
Papers2,241
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,241
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells. | Genome Biol | 2020 | 32085783 | PubTator, text mining | PubMed |
| The Histone Code of Senescence. | Cells | 2020 | 32085582 | PubTator, text mining | PubMed |
| JMJD1B, a novel player in histone H3 and H4 processing to ensure genome stability. | Epigenetics Chromatin | 2020 | 32070414 | PubTator, text mining | PubMed |
| Nucleosome destabilization by nuclear non-coding RNAs. | Commun Biol | 2020 | 32047236 | PubTator, text mining | PubMed |
| Strategies for Mitigating Sexual Desire Discrepancy in Relationships. | Arch Sex Behav | 2020 | 32034534 | PubTator, text mining | PubMed |
| Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma. | Curr Oncol Rep | 2020 | 32030483 | PubTator, text mining | PubMed |
| PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2. | Nucleic Acids Res | 2020 | 32025719 | PubTator, text mining | PubMed |
| Prediction of blood-based biomarkers and subsequent design of bisulfite PCR-LDR-qPCR assay for breast cancer detection. | BMC Cancer | 2020 | 32005108 | PubTator, text mining | PubMed |
| Dual protease type XIII/pepsin digestion offers superior resolution and overlap for the analysis of histone tails by HX-MS. | Methods | 2020 | 32004545 | PubTator, text mining | PubMed |
| Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system. | Methods Enzymol | 2020 | 32000905 | PubTator, text mining | PubMed |
| Epigenetic memory in development and disease: Unraveling the mechanism. | Biochim Biophys Acta Rev Cancer | 2020 | 31982403 | PubTator, text mining | PubMed |
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology. | Int J Clin Oncol | 2020 | 31974683 | PubTator, text mining | PubMed |
| Hepatic Tumor Formation in Adult Mice Developmentally Exposed to Organotin. | Environ Health Perspect | 2020 | 31939706 | PubTator, text mining | PubMed |
| Midline Glioma in Adults: Clinicopathological, Genetic, and Epigenetic Analysis. | Neurol Med Chir (Tokyo) | 2020 | 31902873 | PubTator, text mining | PubMed |
| Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA. | Neurosurg Focus | 2020 | 31896079 | PubTator, text mining | PubMed |
| Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma. | Cancer Chemother Pharmacol | 2020 | 31894347 | PubTator, text mining | PubMed |
| Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high-grade gliomas. | Neuropathol Appl Neurobiol | 2020 | 31859390 | PubTator, text mining | PubMed |
| Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma. | Int J Radiat Oncol Biol Phys | 2020 | 31785339 | PubTator, text mining | PubMed |
| CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. | Toxicol Appl Pharmacol | 2020 | 31734321 | PubTator, text mining | PubMed |
| Structural Heterogeneity in the Preamyloid Oligomers of β-2-Microglobulin. | J Mol Biol | 2020 | 31711963 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8352/papers?page=43